A study of the effect of novel medication on the frequency of nocturnal hypoglycemia in Type 1 Diabetes.

• Aged between 18 and 75 years with immune-mediated Type 1 Diabetes for at least 5 years,

• Receiving multiple daily injections of insulin or continuous subcutaneous insulin infusion as your only Type 1 Diabetes therapy.

• Recent history suggesting risk of nocturnal hypoglycemia (as indicated by TBR54 of ≥1%)

Gain access to cutting-edge medications and treatments before they are widely available.

Our expert team is under the guidance of renowned endocrinologist, Dr. Anastasios Manessis.

We are highly focused on patient well-being and the highest ethical standards in clinical research.